Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chf Solutions Inc (CHFS)

Chf Solutions Inc (CHFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,826
  • Shares Outstanding, K 2,585
  • Annual Sales, $ 5,000 K
  • Annual Income, $ -17,030 K
  • 60-Month Beta 2.28
  • Price/Sales 0.86
  • Price/Cash Flow N/A
  • Price/Book 0.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -8.54
  • Growth Rate Est. (year over year) +11,797.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.25 +17.93%
on 10/14/19
2.30 -35.65%
on 09/24/19
-0.72 (-32.73%)
since 09/17/19
3-Month
1.25 +17.93%
on 10/14/19
3.08 -51.95%
on 07/24/19
-1.18 (-44.36%)
since 07/17/19
52-Week
1.25 +17.93%
on 10/14/19
18.90 -92.17%
on 11/06/18
-13.78 (-90.30%)
since 10/17/18

Most Recent Stories

More News
CHF Solutions to Exhibit at The American College of Chest Physicians (CHEST) Annual Meeting 2019

CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it will be exhibiting at the American College of Chest Physicians' (CHEST) Annual Meeting 2019, on October 21-23, 2019. The conference will be held...

CHFS : 1.48 (-10.84%)
CHF Solutions System to be Used in JAHVH Study After Final Nod

CHF Solutions' (CHFS) Aquadex system to be used for the outpatient study on heart failure, conducted by James A. Haley Veterans' Hospital and Clinics. The study receives final approval.

SYK : 215.56 (-0.09%)
CAPR : 2.71 (-4.58%)
GWPH : 119.12 (-0.62%)
CHFS : 1.48 (-10.84%)
CHF Solutions Announces that James A. Haley Veterans' Hospital Receives Final Approval To Initiate Heart Failure Outpatient Study utilizing Aquadex FlexFlow(R) System

CHF Solutions (Nasdaq: CHFS), today announced that James A. Haley Veterans' Hospital and Clinics (JAHVH), located in Tampa, Florida, has received Institutional Review Board approval to initiate an outpatient...

CHFS : 1.48 (-10.84%)
CHF Solutions, Inc. to Present at the MicroCap Rodeo Investor Conference on October 15, 2019

CHF Solutions, Inc. (Nasdaq: CHFS) today announced that John Erb, the company's chairman and CEO, will be presenting and meeting with investors at the first annual MicroCap Rodeo investor conference on...

CHFS : 1.48 (-10.84%)
CHF Solutions To Exhibit at Upcoming Heart Failure Conferences

CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it will be exhibiting at two Heart Failure conferences during October:

CHFS : 1.48 (-10.84%)
CHF Solutions submits 510(k) application for Use of Aquadex FlexFlow(R) System with Pediatric Patients

CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it has submitted an application to the FDA requesting for 510(k) clearance of the Aquadex FlexFlow system to include pediatric patients who weigh...

CHFS : 1.48 (-10.84%)
Multi-Center, Retrospective Study Evaluates Use of Ultrafiltration Therapy with Aquadex FlexFlow(R) System in Pediatric Patients

CHF Solutions, Inc. (Nasdaq:CHFS) today announced the publication of a multi-center, retrospective study in the Clinical Journal of the American Society of Nephrology evaluating the use of hemofiltration...

CHFS : 1.48 (-10.84%)
CHF Solutions, Inc. to Present at the Ladenburg Thalmann's 2019 Healthcare Conference on September 24, 2019

CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Claudia Napal Drayton, the company's CFO, will be presenting and meeting with investors at the 2019 Landenburg Thalmann's 2019 Healthcare Conference...

CHFS : 1.48 (-10.84%)
CHF Solutions, Inc. to Host a Call with Investigator Panel to Discuss Results of a Study Involving Use of Aquadex FlexFlow(R) in Pediatric Patients on September 25, 2019

CHF Solutions, Inc. (NASDAQ: CHFS) announced today that it will host a conference call and webcast at 1:00 PM ET on Wednesday, September 25, 2019 to discuss the results of a multicenter, retrospective...

CHFS : 1.48 (-10.84%)
CHF Solutions, Inc. to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America

CHF Solutions, Inc. (Nasdaq:CHFS) today announced it would be exhibiting at the 23 Annual Scientific Meeting of the Heart Failure Society of America from September 14-16, 2019. The conference is being...

CHFS : 1.48 (-10.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade CHFS with:

Business Summary

CHF Solutions, Inc. is a medical device company which focused on commercializing the Aquadex FlexFlow (R) System. Its commercial product Aquadex system, is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended ultrafiltration treatment...

See More

Key Turning Points

2nd Resistance Point 1.71
1st Resistance Point 1.60
Last Price 1.48
1st Support Level 1.42
2nd Support Level 1.35

See More

52-Week High 18.90
Fibonacci 61.8% 12.16
Fibonacci 50% 10.08
Fibonacci 38.2% 8.00
Last Price 1.48
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar